Holen Sie sich die Stockscreener-App
1.99
2.45%
-0.05
Handel nachbörslich:
1.95
-0.04
-2.01%
Schlusskurs vom Vortag:
$2.04
Offen:
$2.03
24-Stunden-Volumen:
208.25K
Relative Volume:
0.04
Marktkapitalisierung:
$8.68M
Einnahmen:
$79,300
Nettoeinkommen (Verlust:
$-6.92M
KGV:
-3.1181
EPS:
-0.6382
Netto-Cashflow:
$-5.34M
1W Leistung:
-8.72%
1M Leistung:
+2.58%
6M Leistung:
+224.16%
1J Leistung:
+683.16%
1-Tages-Spanne:
$1.96
$2.09
1-Wochen-Bereich:
$1.96
$2.48
52-Wochen-Spanne:
$0.1299
$8.9999
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
Firmenname
Virax Biolabs Group Ltd
Sektor
Branche
Telefon
-
Adresse
-
Virax Biolabs Group Ltd Aktie (VRAX) Neueste Nachrichten
Virax Biolabs announces 2024 annual meeting - Investing.com India
Virax Biolabs announces 2024 annual meeting By Investing.com - Investing.com UK
Virax Biolabs Sets Date for 2024 AGM - TipRanks
Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know - MSN
Virax Biolabs announces distribution agreement with Europa Biosite - TipRanks
Virax Biolabs Expands Reach with Europa Biosite Deal - TipRanks
EXCLUSIVE: Virax Biolabs Inks Distribution Pact To Commercialize ImmuneSelect Profiling Solutions In UK And Ireland - Yahoo Finance
Pre-market Movers: ALZN, VRAX, APDN, LQDA... - RTTNews
Analyzing the Impact of Earnings Reports on Virax Biolabs Group Ltd Inc. (VRAX) Price Performance - The InvestChronicle
Daily Progress: Virax Biolabs Group Ltd (VRAX) Gain 14.20, Closing at 1.85 - The Dwinnex
Virax Biolabs Plans New Share Offering - TipRanks
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session - MSN
Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Down 72.2% in September - Defense World
Charting the Course: Virax Biolabs Group Ltd’s VRAX Stock Prospects - The InvestChronicle
How did Virax Biolabs Group Ltd (VRAX) fare last session? - US Post News
Daily Market Movement: Virax Biolabs Group Ltd (VRAX) Sees a -3.56 Decrease, Closing at 2.44 - The Dwinnex
Virax Biolabs Group Ltd (VRAX)’s Day in Review: Closing at 2.84, Up by 9.65 - The Dwinnex
Virax Biolabs Group Ltd Inc. (VRAX) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
A closer look at VRAX’s price-to-free cash flow ratio - US Post News
Cosmos Health expands mpox kit distribution to Gulf States - Investing.com India
Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar - Lelezard
Ratios Reveal: Breaking Down Virax Biolabs Group Ltd (VRAX)’s Financial Health - The Dwinnex
VRAX’s 2023 Market Dance: Up 140.41% – Time to Invest? - The InvestChronicle
Investing in Virax Biolabs Group Ltd (VRAX) might be an excellent idea, but the stock is currently overvalued/undervalued – US Post News - US Post News
Closing Figures Unveiled: Virax Biolabs Group Ltd (VRAX) Drop -12.90, Closes at 3.51 - The Dwinnex
Virax Biolabs Group Ltd (VRAX) requires closer examination - US Post News
Post-Trade Analysis: Virax Biolabs Group Ltd (VRAX) Slides -7.91, Closing at 4.66 - The Dwinnex
Virax Biolabs Group Ltd (VRAX) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Luminar Technologies Inc (NASDAQ: LAZR) Shares Look Bullish In 2024 - Stocks Register
NuCana halts NuTide:323 study on colorectal cancer - Investing.com
NuCana halts NuTide:323 study on colorectal cancer By Investing.com - Investing.com Australia
Virax Biolabs to Participate at 7th European Congress of Immunology - Quantisnow
Wall Street-Heavily Traded - WDRB
Russia bans entry to dozens of American journalists, including WSJ, NYT and Washington Post - CNN International
Virax stock soars on Mpox tests deal in Europe and Middle East - Invezz
Virax Biolabs expands Mpox test kit distribution in Europe, GCC By Investing.com - Investing.com Australia
EXCLUSIVE: Virax Biolabs Inks Distribution Pact For Mpox Diagnostic Kits In Europe And Middle East - Yahoo Finance
Virax Biolabs signs distribution agreement for Mpox virus detection kits - TipRanks
Virax Biolabs Group Ltd (VRAX) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle
Closing Figures: Virax Biolabs Group Ltd (VRAX)’s Negative Finish at 4.61, Down -15.41 - The Dwinnex
There is no way Virax Biolabs Group Ltd (VRAX) can keep these numbers up - SETE News
Monkeypox Stocks Round 2: Mpox Stocks - Wealth Daily
Virax Biolabs Introduces New Share Purchase Warrant - TipRanks
Pre-market Movers: SQNS, MNTS, UBXG, PRTG, PTWO… - RTTNews
Canadian government forces rail lockout to end - CNN International
Pixie Dust Technologies, Inc. Announces Fiscal Year 2024 Financial Results - Quantisnow
Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Fake celebrity endorsements become latest weapon in misinformation wars, sowing confusion ahead of 2024 election - CNN International
Canadian freight railroads shut down, dealing a potential blow to North America’s economy - CNN International
Cosmos Health secures distribution rights for mpox PCR kits - Investing.com India
Judge blocks Arizona lithium drilling that tribe says is threat to sacred lands - 69News WFMZ-TV
Finanzdaten der Virax Biolabs Group Ltd-Aktie (VRAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.02%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):